Novartis AG
Company Profile
Other Listings & Derivatives(1)
Business Description
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative Medicines, which develops and markets cutting-edge pharmaceutical treatments, and Sandoz, a leading generics business. Novartis medicines reach millions of patients worldwide through a diverse portfolio of prescription drugs and specialty pharmaceuticals. The company serves patients, healthcare professionals, and societies globally, combining research and development capabilities with advanced manufacturing and distribution infrastructure. Novartis maintains a strong presence across major markets, with research facilities and operations in multiple countries. The company's commitment centers on developing treatments for serious and life-threatening conditions while ensuring broad patient access to medical innovations through its global network.
Profitability & Growth
Profitability
Recent Year-End
Balance Sheet Snapshot
Total Cash (MRQ)
5.58B
Total Debt (MRQ)
38.04B
Current Ratio (MRQ)
0.85
Book Value / Share
16.25